10:01 AM EST, 11/05/2024 (MT Newswires) -- Andrew Cheng, Director, President and CEO, on November 01, 2024, sold 108,366 shares in Akero Therapeutics ( AKRO ) for $3,438,312. Following the Form 4 filing with the SEC, Cheng has control over a total of 605,417 shares of the company, with 605,417 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1744659/000095017024121100/xslF345X05/ownership.xml

Price: 31.61, Change: -0.44, Percent Change: -1.39